Delivery Order SPE2DB22D1017-SPE2DB24FG4FR

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,303.49 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,504,602 dapagliflozin 10 mg tablets. The order has an ultimate completion date of August 20, 2024 and is not set aside. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide range...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,792,661 tablets of the prescription medication Dapagliflozin 10 mg. The award, valued at $5,785.78, was made by the Defense Logistics Agency (DLA), a defense agency, on June 3, 2024. The contract has a completion date of June 4, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.54 firm-fixed-price delivery order is for the supply of 4,566,150,890 units of the medication Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,611.02 firm-fixed-price delivery order is for the supply of 4,565,766,279 units of the prescription drug dapagliflozin 10 mg tablets. The contract has an ultimate completion date of September 12, 2024 and does not utilize a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA...
This federal contract award to AmerisourceBergen Drug Corp is a $11,573.61 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) for the supply of 4,565,364,750 tablets of 10 mg Dapagliflozin, a prescription medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these critical medical products to support military treatment facilities and healthcare programs. This award is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,376.58 contract is for the supply of 4,567,951,816 units of the diabetes medication Dapagliflozin 10 mg tablets. The award has an ultimate completion date of April 18, 2025 and is not a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,932.76 firm fixed price delivery order is for the supply of 4,566,177,485 dapagliflozin 10 mg tablets. The award has an ultimate completion date of October 23, 2024 and was made on October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $33,415.79, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,617,733 units of the prescription drug Dapagliflozin 10 mg tablet. The contract has an ultimate completion date of August 29, 2024, and is a firm fixed-price delivery order. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG4FR
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,041.36 fixed-price delivery order is for the supply of 4,565,634,033 tablets of the prescription drug Dapagliflozin 10 mg. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as several other Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, collectively worth up to $1.75 billion, to provide a wide range of medical commodities, prescription drugs, and supplies to support federal healthcare programs and facilities. This contract does not have a set-aside designation.

Generated 11/28/24, 9:11 AM